THERESE NOVAK: Open Payments
NPI 1699803361 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 8 payments from 8 companies in 2025. Trend: 2023 $462 · 2024 $176 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $114 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $112 |
| AstraZeneca Pharmaceuticals LP | 1 | $110 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Gilead Sciences, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: Auvelity, IBSRELA, JARDIANCE, XIFAXAN, AIRSUPRA, INSPIRE, Epclusa, CAPLYTA.
Industry payments across LA — which companies pay providers there.
